A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer

European Journal of Cancer

Volumn 43, Issue 13, 2007, Pages 1905-1917

  Lord, S J ^a   Lei, W ^a   Craft, P ^b,c   Cawson, J N ^d   Morris, I ^e   Walleser, S ^a   Griffiths, A ^a   Parker, S ^a   Houssami, N ^f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c The Australian National University   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e KING EDWARD MEMORIAL HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

BRCA1 protein; BRCA2 protein; Breast neoplasms; Magnetic resonance imaging; Mass screening; Sensitivity and specificity

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ECHOGRAPHY; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; BREAST NEOPLASMS; EARLY DIAGNOSIS; FALSE POSITIVE REACTIONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 34548132358     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.06.007     Document Type: Article

References (30)

1. Antoniou A., Pharoah P.D., Narod S., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 (2003) 1117-1130
2. Collaborative group on hormonal factors in breast cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-99.
3. Cuzick J., Forbes J., Edwards R., et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360 (2002) 817-824
4. Hartmann L.C., Schaid D.J., Woods J.E., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med 340 (1999) 77-84
5. Houssami N., and Wilson R. Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?. Breast 16 (2007) 2-4
6. Duffy S.W., Tabar L., and Smith R.A. The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA: Cancer J Clin 52 (2002) 68-71
7. Humphrey L.L., Helfand M., Chan B.K., and Woolf S.H. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 347-360
8. International Agency for Research on Cancer (IARC). Breast cancer screening. 7, IARC Handbooks of Cancer Prevention, Lyon: IARC Press; 2002.
9. Liberman L. Breast cancer screening with MRI - what are the data for patients at high risk?. New Engl J Med 351 (2004) 497-500
10. Hamilton L.J., Evans A.J., Wilson A.R., et al. Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clin Radiol 59 (2004) 895-902
11. Tilanus-Linthorst M., Verhoog L., Obdeijn I.M., et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 102 (2002) 91-95
12. National Collaborating Centre for Primary Care. Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Partial update of NICE clinical guideline 14.
13. Saslow D., Boetes C., Burke W., et al. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA: Cancer J Clin 57 (2007) 75-89
14. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
15. MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-78.
16. Lehman C.D., Blume J.D., Weatherall P., et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103 (2005) 1898-1905
17. Sardanelli F., Podo F., D'Agnolo G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): interim results. Radiology 242 (2007) 698-715
18. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J Am Med Assoc 292 (2004) 1317-1325
19. Irwig L., Houssami N., and van Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer 90 (2004) 2118-2122
20. National Breast Cancer Centre (NBCC). Magnetic resonance imaging for the early detection of breast cancer in women at high risk: a systematic review of the evidence. Camperdown: NBCC; 2006.
21. Whiting P., Rutjes A., Reitsma J., Bossuyt P., and Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3 (2003) 25
22. Zamora J, Muriel A, Abraira V. Meta_DiSc for Windows: a software package for the meta-analysis of diagnostic tests. [accessed 03.02.07].
23. Egger M., Davey Smith G., and Altman D.G. Systematic reviews in health care: meta-analysis in context. 2nd ed. (2001), BMJ Publishing Group, London
24. Ganott M.A., Sumkin J.H., King J.L., et al. Screening mammography: do women prefer a higher recall rate given the possibility of earlier detection of cancer?. Radiology 238 (2006) 793-800
25. Irwig L., Houssami N., Armstrong B., and Glasziou P. Evaluating new screening tests for breast cancer. BMJ 332 (2006) 678-679
26. Kriege M., Brekelmans C.T.M., Boetes C., et al. Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition. Obstet Gynecol Surv 60 (2005) 107-109
27. Kriege M., Brekelmans C.T., Boetes C., et al. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 106 (2006) 2318-2326
28. Plevritis S.K., Kurian A.W., Sigal B.M., et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295 (2006) 2374-2384
29. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138 (2003) W1-W12
30. The Medical Services Advisory Committee. Breast magnetic resonance imaging, MSAC Application 1098. Canberra: Commonwealth of Australia; 2007.